Skip to main content
Main menu
About
Our Mission
Donors
Board of Directors
Advisory Boards
Staff
Careers
Who we are
FAQ
Annual Report
Why New TB Drugs?
Global Pandemic
Inadequate Treatment
Antimicrobial Resistance
Maternal and Child Health
Cycle of Poverty
R&D
Scientific Vision
Pipeline
Discovery
Engaging Communities
Access
Our Commitment
Access in TB Market
Child-friendly medicines
Pretomanid and BPaL
Pathways to Access BPaL
News
Latest News
Publications
Voices of TB
Research Papers
Making an Impact
Donate
Search form
Search
News Archive
June 13, 2005
Nonprofit to test novel tuberculosis drug worldwide
June 13, 2005
First Tuberculosis Drug Developed by a Non-profit Begins Clinical Trials
June 7, 2005
TB Drug Research Picks Up the Pace
May 11, 2005
Event Spotlight: Gordon Research Conference on TB Drug Development
May 11, 2005
Developing Countries Innovating for Global Health
May 11, 2005
The British Department for International Development (DFID) Outlines Role Pharmaceutical Industry Can Play in Access to Essential Medicines
May 11, 2005
TB Control: Challenges Ahead
May 11, 2005
TB Alliance Expands Discovery Projects with GlaxoSmithKline
May 8, 2005
The Vision Behind the Compound: PA-824 Architects
April 27, 2005
Research of neglected diseases gets shot in arm
Pages
«
‹
…
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
…
›
»
